Acasti pharma inc. discusses clinical progress of lead assets and 2022 catalysts with the stock day podcast

Phoenix, arizona--(newsfile corp. - september 21, 2022) - the stock day podcast welcomed acasti pharma inc. (nasdaq: acst) ("the company"), a specialty pharma company with drug delivery technologies and drug candidates addressing rare and orphan diseases. ceo of the company, jan d'alvise, joined stock day host everett jolly.

ACST Ratings Summary

ACST Quant Ranking